Heart disease affects over 30.3 million adults in the United States and is a leading cause of mortality, morbidity, and disability. However, little is known about the relationship between exposure to incarceration and chronic disease. Therefore, the aim of this study was to assess the relationship between prior incarceration and heart disease. This was a study of 12,686 adults from the National Longitudinal Survey of Youth (NLSY) 1979 dataset. History of incarceration was the predictor and defined as any episode of incarceration in a correctional institution. The outcome, heart disease, was defined as self-reported diagnosis of heart disease. Covariates included: Demographic factors (age, race, sex, place of residence, and marital status), lifestyle and clinical factors (drug use, body mass index (BMI), early life health limitation, cigarette smoking, and binge drinking), and socioeconomic factors (poverty status, educational attainment, and employment status). Pooled logistic regression models with generalized estimating equation approach (GEE) were used to model the relationship between history of incarceration and heart disease. In the unadjusted analyses, a history of incarceration was significantly associated with an increased odds of heart disease (OR 2.29; 95% CI 1.40, 3.75). This relationship persisted after adjusting for demographic (OR 3.46; 95% CI 2.06, 5.85) and lifestyle and clinical factors (OR 3.46; 95% CI 2.03, 5.88) and socioeconomic factors (OR 2.14; 95% CI 1.25, 3.67). In this sample of adults, a history of incarceration was significantly associated with heart disease, after adjusting for demographic, lifestyle and clinical factors, and socioeconomic factors. These findings suggest that exposure to incarceration may heighten susceptibility to heart disease. Further research is needed to elucidate the mechanisms through which incarceration impacts cardiovascular health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healthplace.2022.102808 | DOI Listing |
ACS Sens
January 2025
Sensor Engineering Department, Faculty of Science and Engineering, Maastricht University, P.O. Box 616, 6200 MDMaastricht, The Netherlands.
Malaria is a major public healthcare concern worldwide, representing a leading cause of death in specific regions. The gold standard for diagnosis is microscopic analysis, but this requires a laboratory setting, trained staff, and infrastructure and is therefore typically slow and dependent on the experience of the technician. This study introduces, for the first time, a biomimetic sensing platform for the direct detection of the disease.
View Article and Find Full Text PDFAnn Emerg Med
January 2025
Department of Emergency Medicine, University of Minnesota, Minneapolis, MN; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN.
The traditional management of acute coronary syndrome has relied on the identification of ST-segment elevation myocardial infarction (STEMI) as a proxy of acute coronary occlusion. This conflation of STEMI with acute coronary occlusion has historically overshadowed non-ST-segment elevation myocardial infarction (NSTEMI), despite evidence suggesting 25% to 34% of NSTEMI cases may also include acute coronary occlusion. Current limitations in the STEMI/NSTEMI binary framework underscore the need for a revised approach to chest pain and acute coronary syndrome management.
View Article and Find Full Text PDFJACC Clin Electrophysiol
January 2025
Montreal Heart Institute, Montreal, Québec, Canada.
Background: Ventricular tachycardia (VT) substrate characteristics before transcatheter pulmonary valve replacement (TPVR) in repaired tetralogy of Fallot (rTOF) are unknown.
Objectives: In this study, the authors sought to evaluate substrates for sustained monomorphic VT before TPVR in rTOF.
Methods: Retrospective (2017 to 2021) and prospective (commencing 2021) rTOF patients with native right ventricular outflow tract referred for electrophysiology study (EPS) before TPVR were included.
Value Health Reg Issues
January 2025
Novartis Singapore Pte Ltd, Singapore. Electronic address:
Objectives: This analysis evaluated the cost-effectiveness of inclisiran plus standard of care (SoC; comprising statins, ezetimibe, and fenofibrate) in primary hypercholesterolemia or mixed dyslipidemia from a Singapore healthcare system perspective. Inclisiran + SoC was separately compared with SoC, alirocumab + SoC, and evolocumab + SoC.
Methods: A lifetime Markov model in the United Kingdom (UK) was adapted to the Singapore setting.
Heart Lung Circ
January 2025
Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Vic, Australia; Department of Paediatrics, University of Melbourne, Parkville, Vic, Australia. Electronic address:
Diabetes is becoming more common worldwide, and people with diabetes are twice as likely to experience heart problems compared to those without diabetes. These cardiovascular complications are the foremost cause of mortality among people with diabetes. A specific form of heart failure known as "diabetic cardiomyopathy" can develop in individuals with diabetes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!